Biocon says to take Syngene unit public
Biocon Ltd will list its research services business arm Syngene by selling up to 15 percent stake in a public offer, the company said, after reporting third-quarter earnings.
Jan 23, 2015, 09:06 AM IST
Biocon Ltd will list its research services business arm Syngene by selling up to 15 percent stake in a public offer, the company said, after reporting third-quarter earnings.
Jan 23, 2015, 09:06 AM IST